SFCM
RLAY icon

Seven Fleet Capital Management’s Relay Therapeutics RLAY Stock Holding History

Seven Fleet Capital Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.56M Buy
257,738
+184,738
+253% +$1.65M 0.81% 34
2025
Q4 		$618K Buy
+73,000
New +$521K 0.42% 44

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Seven Fleet Capital Management's RLAY Position: Q1 2026 in Review

Seven Fleet Capital Management increased its Relay Therapeutics (RLAY) stake by 253% in Q1 2026, buying an estimated $1.65M and bringing the position to 257,738 shares worth $2.56M. The position accounts for 0.81% of the portfolio, ranked #34.

Seven Fleet Capital Management first reported a position in RLAY in Q4 2025 and has held it in 2 quarters since. 243 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • Seven Fleet Capital Management held 257,738 shares of Relay Therapeutics worth $2.56M as of Q1 2026.
  • Seven Fleet Capital Management bought 184,738 Relay Therapeutics shares in Q1 2026, an estimated $1.65M.
  • Relay Therapeutics made up 0.81% of Seven Fleet Capital Management's portfolio in Q1 2026, its #34 holding.
  • Seven Fleet Capital Management first reported a position in Relay Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 243 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.